OpenAlex
Works that cite this article, indexed by OpenAlex.
Curcumin-Based Nanomedicines in the Treatment of Inflammatory and Immunomodulated Diseases: An Evidence-Based Comprehensive Review
Pharmaceutics 15(1) (2023)
Lucas Fornari Laurindo; Gabriel Magno de Carvalho; Bárbara de Oliveira Zanuso; Maria Eduardo Figueira; Rosa Direito; Ricardo de Álvares Goulart; Daiene Santos Buglio; Sandra Maria Barbalho
Oligodendrocyte progenitor cells in Alzheimer’s disease: from physiology to pathology
Translational Neurodegeneration 12(1) (2023)
Peibin Zou; Chongyun Wu; Timon Cheng‐Yi Liu; Rui Duan; Luodan Yang
Curcumin-based nanotechnology approaches and therapeutics in restoration of autoimmune diseases
Journal of Controlled Release 348 (2022)
Niloufar Rahiman; Yuliya V. Markina; Prashant Kesharwani; Thomas Patrick Johnston; Amirhossein Sahebkar
Curcumin, inflammation, and neurological disorders: How are they linked?
Integrative Medicine Research 12(3) (2023)
Prachi Garodia; Mangala Hegde; Ajaikumar Bahulayan Kunnumakkara; Bharat Bhushan Aggarwal
Role of Plant Phytochemicals: Resveratrol, Curcumin, Luteolin and Quercetin in Demyelination, Neurodegeneration, and Epilepsy
Antioxidants 13(11) (2024)
Mikołaj Grabarczyk; Weronika Szczepańska; Joanna Czpakowska; Ewa Smolińska; Aleksandra Szychowska; Andrzej R Glabinski; Piotr Szpakowski
Insights Into the Role of Copper in Neurodegenerative Diseases and the Therapeutic Potential of Natural Compounds
Current Neuropharmacology 22(10) (2023)
Guangcheng Zhong; Xinyue Wang; Jiaqi Li; Zhouyuan Xie; Qiqing Wu; Jiaxin Chen; Yiyun Wang; Ziying Chen; Xinyue Cao; Tianyao Li; Jinman Liu; Qi Wang
White Matter in Crisis: Oligodendrocytes and the Pathophysiology of Multiple Sclerosis
Cells 14(18) (2025)
Mario García‐Domínguez
Progress in the Application of Drugs for the Treatment of Multiple Sclerosis
Frontiers in Pharmacology 12 (2021)
Weipeng Wei; Denglei Ma; Lin Li; Lan Zhang
Dual Mechanism of Action of Curcumin in Experimental Models of Multiple Sclerosis
International Journal of Molecular Sciences 23(15) (2022)
Ines ELBini-Dhouib; Maroua Manai; Nour-elhouda Neili; Soumaya Marzouki; Ghada Sahraoui; Warda Ben Achour; Sondes Zouaghi; Mélika Ben Ahmed; Raoudha Doghri; Najet Srairi‐Abid
Total astragalosides promote oligodendrocyte precursor cell differentiation and enhance remyelination in cuprizone-induced mice through suppression of Wnt/β-catenin signaling pathway
Journal of Ethnopharmacology 298 (2022)
Jinfeng Yuan; Nuo Xu; Yanlin Tao; Xinyan Han; Yang Liu; Jinglei Liang; Haojieyin Jin; Xiaoxia Zhang; Hui Wu; Hailin Shi; Fei Huang; Xiaojun Wu
Involvement of Microglia in Neurodegenerative Diseases: Beneficial Effects of Docosahexahenoic Acid (DHA) Supplied by Food or Combined with Nanoparticles
International Journal of Molecular Sciences 22(19) (2021)
Karine Charrière; Imen Ghzaiel; Gérard Lizard; Anne Véjux
Harnessing nanomedicine for modulating microglial states in the central nervous system disorders: Challenges and opportunities
Biomedicine & Pharmacotherapy 177 (2024)
Haisong Li; Meng Guan; Ning-Ning Zhang; Yizhuo Wang; Tingting Liang; Haitao Wu; Chang Wang; Tianmeng Sun; Shuhan Liu
Mechanistic insight of curcumin: a potential pharmacological candidate for epilepsy
Frontiers in Pharmacology 15 (2025)
Saima Khatoon; Nida Kalam
Antioxidant Therapies in the Treatment of Multiple Sclerosis
Biomolecules 14(10) (2024)
Félix Javier Jiménez‐Jiménez; Hortensia Alonso‐Navarro; Paula Salgado-Cámara; Elena García‐Martín; José A. G. Agúndez
The ameliorative effects of curcumin nanomicelle on testicular damage in the mouse model of multiple sclerosis
BMC Complementary Medicine and Therapies 24(1) (2024)
Farhad Koohpeyma; Zahra Khodaparast; Sara Salehi; Sina Danesh; Farhad Mohammadi Gheshlagh; Arzhang Naseri; Nima Montazeri‐Najafabady
Curcumin ameliorates astrocyte inflammation through AXL in cuprizone-induced mice
Toxicology and Applied Pharmacology 494 (2024)
Wenjing Zhang; Mengjiao Sun; Ning Liu; Xiaoling Li; Jing Sun; Manxia Wang
Targeting the brain lesions using peptides: A review focused on the possibility of targeted drug delivery to multiple sclerosis lesions
Pharmacological Research 167 (2021)
Atefeh Rayatpour; Mohammad Javan
Therapeutic opportunities for targeting cellular senescence in progressive multiple sclerosis
Current Opinion in Pharmacology 63 (2022)
Pearl A. Sutter; Mark G. McKenna; Jaime Imitola; Robert S. Pijewski; Stephen J. Crocker
The Role of Oligodendrocyte Lineage Cells in the Pathogenesis of Alzheimer’s Disease
Neurochemical Research 50(1) (2025)
Xiaodong Liu; Zhengxiang Lv; Qin Huang; Yihui Lei; Haijun Liu; Ping Xu
TLR4 Associated Signaling Disrupters as a New Means to Overcome HERV-W Envelope-Mediated Myelination Deficits
Frontiers in Cellular Neuroscience 15 (2021)
Peter Göttle; Kira Schichel; Laura Reiche; Luisa Werner; Annika Zink; Alessandro Prigione; Patrick Küry
Effect of Intranasal Administration of Adipose-Derived Mesenchymal Stem Cells on Acute Demyelination in Mouse Corpus Callosum
Journal of Microscopy and Ultrastructure (2024)
Nesma Mohamed; Mohamed Abd El Rahman Ahmed Mekawy; Safaa Mohammed Shaker; Ghada Galal Hamam
Intranasal adipose-derived stem cells mitigate cuprizone-induced demyelination in mouse corpus callosum by modulating oligodendrocyte and microglial marker expression: histological and ultrastructural insights
Journal of Molecular Histology 56(5) (2025)
Nesma Mohamed Mohamed; Mohamed Abd El Rahman Ahmed Mekawy; Safaa Mohammed Shaker; Ghada Galal Hamam